Amant

Quick links to important sections

Amant

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amant

Quick Facts

Property Description
Active ingredient Bromazepam
Form Tablet (Oral preparation)
Pharmacological class Anxiolytic / Benzodiazepine
Common purpose Relief of nervous tension and anxiety
Origin Synthetic compound

What is Amant and What Class Does it Belong To?

Amant is a prescription-only medicine (POM) containing the active ingredient Bromazepam, fundamentally classifying it as a psychotropic drug for adult patients. The compound belongs to the benzodiazepine group, which is widely recognized as an established treatment modality for acute tension states, falling into the pharmacological class of anxiolytics and tranquilizers. Bromazepam is used to manage pronounced states of tension and anxiety. As a central nervous system depressant, Amant is specifically designed to modulate brain activity to achieve a targeted, systemic calming effect.

Composition, Form, and Origin of Bromazepam

The active ingredient, Bromazepam, is a synthetic compound, manufactured through chemical synthesis and is not naturally sourced. Amant is a single-ingredient product formulated as a solid tablet, making it an oral preparation suitable for the oral route of administration. This dosage form is the standard and most clinically recognized way to deliver the systemic effects of Bromazepam. Unlike some very long-acting benzodiazepines, Bromazepam is often positioned for its comparatively moderate half-life. The tablet comprises the precise amount of the active substance combined with pharmaceutical-grade solid excipients for stability and controlled delivery.

What is the General Purpose of Amant?

The general purpose of Amant is to serve as an effective anxiolytic and tranquilizer, aiming to alleviate states of intense nervous tension and distress. Its function is achieved by modulating the body's natural inhibitory systems to gently reduce overall neuronal excitability. This specific action is clinically recognized for reducing agitation and promoting composure. The overarching utility of this psychotropic drug is to promote a state of general calmness and repose, thereby effectively mitigating both psychological agitation and the associated physical symptoms, known as somatic manifestations of anxiety, often seen in stress-related conditions.

Regulatory References

  1. NIH DailyMed label for a Bromazepam-containing product

What side effects are possible with Amant?

Possible Side Effects and Safety Information

The safety profile of Amant, which contains the benzodiazepine Bromazepam, is officially categorized by regulatory bodies based on the frequency and physiological system affected. Adverse reactions are primarily related to the central nervous system (CNS) and its effects are typically more noticeable at the beginning of treatment.

Frequency-Classified Adverse Reactions

The most frequently reported effects, classified as Common (may affect up to 1 in 10 people), include drowsiness, sedation, fatigue, decreased alertness, dizziness, headache, and ataxia (impaired coordination). Other potential effects listed in regulatory documents involve the gastrointestinal system (e.g., nausea, constipation) and the musculoskeletal system (muscle weakness).

Serious Adverse Reactions and Safety Constraints

A critical, documented safety element is the risk of physical and psychological drug dependence, which increases with prolonged use. Abrupt cessation after extended use can lead to a withdrawal syndrome. Regulatory labeling also identifies rare, serious adverse reactions known as paradoxical reactions, such which can include aggression, hostility, agitation, or hallucinations.

Population-Specific Considerations

Specific caution is warranted for certain patient groups. Older adults may have an increased sensitivity to CNS effects, contributing to a higher risk of falls. The medicine is formally contraindicated in patients with pre-existing conditions such as Myasthenia Gravis, severe respiratory insufficiency, and severe hepatic insufficiency.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile of Amant (Bromazepam) overdose defines a spectrum of Central Nervous System (CNS) depression, ranging from milder presentations like somnolence, slurred speech, and ataxia to profound sedation and a stuporous or comatose state. The documented physiological systems affected include the CNS, respiratory system (depression and apnea), and the cardiovascular system (hypotension and bradycardia).

When to Seek Urgent Help

Regulatory documentation mandates that individuals must seek immediate medical attention for all suspected overdoses. Emergency services must be contacted immediately if the person exhibits severe, life-threatening symptoms, such as profound sedation, loss of consciousness, or difficulty breathing. The risk of death is noted to be significantly increased when the drug is co-ingested with other CNS depressants, particularly alcohol or opioids.

Management is primarily founded on supportive care and close clinical observation. The specific antagonist, Flumazenil, is available but its use is generally reserved for the most critical, life-threatening respiratory or cardiovascular compromise. Regulatory documents also note that elderly patients and very young children are populations with increased susceptibility to the severe CNS depressant effects.

Therapeutic Uses of Amant

What Amant Treats: Main Uses and Benefits

The core therapeutic area for Amant is the short-term symptomatic relief of excessive anxiety in patients experiencing anxiety disorders. This supports its role in symptomatic management for conditions characterized by periods of high emotional tension and distress.

Therapeutic Scope and Key Indications

Amant is relevant for managing symptom clusters, which include severe anxiety disorders, intense nervous tension states, and acute episodes of panic or high emotional excitation. It is also applied in addressing symptoms related to physical discomfort (somatic manifestations) linked to psychological tension. The medication is considered relevant when supportive symptom management is appropriate, often applied during phases where symptoms become more noticeable and create noticeable physiological strain.

“The medication is used when symptoms create noticeable functional strain and provides support that helps ease the overall symptom burden.”

Patient Benefit in Acute Contexts

Amant is applied across domains where additional symptomatic support is needed to help moderate the intensity of psychological distress and related physical discomfort. When symptoms suddenly escalate and become temporarily overwhelming, Amant provides support that helps with maintaining functional stability and offers symptomatic relief that helps patients cope more steadily. It is also commonly used to help with promoting calmness (premedication) prior to minor medical or surgical procedures.


Quick Fact: Supportive Management for Heightened Symptoms Amant is relevant for managing symptoms related to psychic agitation and chronic nervous tension, which contributes to improved comfort during symptomatic periods.

Regulatory References

  1. BROMAZEPAM Product Monograph

Eligibility and Restrictions for Use

Who can and cannot use Amant?

Amant is officially permitted for use in adult patients aged 18 years and older. Regulatory documents strictly define populations who must not use this medicine due to safety considerations outlined in official labeling. Absolute contraindications include known hypersensitivity to any benzodiazepine, severe hepatic insufficiency, severe respiratory insufficiency, myasthenia gravis, and sleep apnoea syndrome. Use is also prohibited in patients with rare hereditary problems of galactose or lactose intolerance.

Age and Physiological Restrictions

The medicine is not recommended for children under 18 years of age because its safety and efficacy have not been established in this population. Elderly patients require enhanced monitoring and reduced initial doses, and long-term use is generally advised against. Use in patients with impaired renal function or mild to moderate hepatic impairment requires special caution, often necessitating mandatory dosage adjustments.

Comorbidity and Reproductive Status

Amant is generally not recommended for pregnant or nursing women, as the active substance passes into breast milk and poses a risk to the fetus or infant. Extreme caution is mandated for patients with a documented history of alcohol or drug abuse due to a high risk of dependence, and the drug is not recommended as primary therapy for pre-existing depression.

What should I know about interactions with other medicines?

The official interaction profile for Amant is primarily defined by two major domains: Pharmacodynamic (PD) reinforcement with other central nervous system (CNS) depressants and Pharmacokinetic (PK) alteration by enzyme inhibitors. Regulatory sources strictly advise that the concomitant use of Amant with alcohol, opioids, and other CNS depressants (including antipsychotics and sedative H1-antihistamines) must be avoided. This is due to the documented potential for additive effects resulting in severe sedation, clinically relevant respiratory depression, coma, or death.

Amant’s clearance is also affected by agents that inhibit specific hepatic enzymes. The co-administration with strong CYP inhibitors significantly increases the plasma concentration of bromazepam by reducing its clearance. Specifically, medicinal products such as Cimetidine and Fluvoxamine are documented to reduce clearance and prolong the elimination half-life, which can increase overall exposure to Amant. This PK interaction requires regulatory caution.

A formalized restriction also exists for specific populations, noting that the combination of Amant with opioids requires special care in elderly people due to a heightened risk of additive respiratory depressive effects. No mandatory dose timing separation rules are documented in the official regulatory texts.

Mechanism of Action

How Amant Works: Biological Targets and Mechanisms

Amantadine is a pharmacological agent with a multi-pronged mechanism of action, targeting distinct pathways in the central nervous system (CNS) and a specific viral protein. This dual-system influence reflects its action across distinct mechanistic domains. The drug's activity acts to modulate overactive or dysregulated biological processes, resulting in an altered state of signaling activity.

Modulating Dopamine Neurotransmission

Amant acts within the brain's dopaminergic system. The drug influences this system by promoting the release of stored dopamine and inhibiting its reuptake back into the nerve terminals. This action increases the concentration of available dopamine in the synaptic space, which contributes to altered signaling kinetics within the targeted neural circuits.

Non-Competitive NMDA Receptor Antagonism

The drug acts as a non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptor, a major target in the highly excitatory glutamatergic pathway. By interfering with this receptor, Amant effectively dampens excessive excitatory signaling in the CNS. This acts to limit the propagation of high-frequency signaling events within the CNS.

M2 Ion Channel Blockade (Antiviral Domain)

Amant also exerts a mechanism specific to certain pathogens by physically binding to and blocking the viral M2 proton ion channel of the Influenza A virus. By blocking this channel, the drug interrupts an early molecular step, initiating or suppressing the signaling sequence required for viral spread, contributing to the suppression of viral particle assembly.

Dosage and Administration Information

Instruction Map: How to use Amant — Administration Guidelines

This map summarizes the administration guidelines for Amant (Bromazepam).

Feature Guideline
Route of administration: Oral route only, using the tablet form.
Dosing schedule: Outpatient Dose: Usual daily dose ranges from 6 mg to 18 mg, with treatment often beginning at a lower dose and gradually increasing. Maximum dose in general practice should not exceed 18 mg daily. Severe Cases: In monitored, severe, or hospitalized cases, doses up to 60 mg daily may be used.
Timing in relation to meals (if applicable): The medicine may be taken with or without food. Administration is typically in divided doses, though the evening dose may be larger to consolidate intake.
Preparation requirements (if applicable): No dilution or special preparation is required. Tablets are often scored, allowing for division into equal halves to facilitate dose adjustment.
Age-group administration rules: Older Adults: A reduced dosage is mandatory, often starting at half the usual adult dose (e.g., maximum of 3 mg daily in divided doses). Pediatric Use: Generally not recommended due to lack of established guidelines.
Special procedural conditions: Hepatic/Renal Impairment: Patients require lower doses and close monitoring. Duration: Treatment is limited to short-term use and should not exceed 8 to 12 weeks, including the taper period.

Instruction Classifications (High-Level)

Classification Parameter
Administration method type: Oral (Tablet).
Frequency pattern: Daily use, administered in divided doses (multiple times per day).
Basis of use: Established clinical documentation.
Use-context constraints: Restricted to short-term management; requires gradual dose tapering upon discontinuation.

Resulting Procedural Structure

Step sequence:

  • Treatment is initiated with the lowest effective dose to ensure patient tolerance.
  • The dose is administered in divided portions throughout the day (two or three times daily).
  • The total daily dose should be administered for the shortest possible duration, not to exceed 12 weeks.
  • When ending administration, the dose must be progressively reduced (tapered) to avoid discontinuation phenomena.

Connection to the Overall Use Protocol

The usage protocol dictates a strict oral administration schedule, starting low and typically using divided doses to manage daily requirements. This protocol centers on short-term intervention, with clear limits on total duration and a requirement for gradual dose tapering when cessation is planned. Furthermore, the instructions specify dose reductions to accommodate the altered processing capacities of older adults and patients with hepatic or renal impairment.

Recent Clinical Evidence

Recent Clinical Evidence

Clinical trials have been conducted to evaluate the effect of Amant (Amantadine) on various conditions, including specific neurological disorders and, more recently, persistent post-viral fatigue. The research is focused on assessing its association with changes in symptom severity and documenting its safety profile.


Efficacy and Symptom Assessment

Large-scale clinical trials have assessed whether the drug is associated with changes in symptom severity over a defined period. One randomized controlled clinical trial investigated the effect of Amantadine versus a control group on post-COVID-19 fatigue using the Visual Analog Fatigue Scale (VAFS) and the Fatigue Severity Scale (FSS).

  • Study Findings: In this two-week trial, the group receiving Amantadine demonstrated a significantly greater reduction in both VAFS and FSS scores compared to the control group.
  • Duration: Clinical studies commonly evaluate the effects of administration over periods such as 8 to 12 weeks for full characterization of symptomatic changes.

Safety Profile and Trial Exclusions

Studies have documented the incidence of adverse events in adult participants. Headache and fatigue were among the most frequently documented adverse events in trials. Less common events that were reported included nausea and mild dizziness.

  • Trial Exclusions: Participants with pre-existing moderate or severe cardiac conditions were typically excluded from the research trials. This means safety and efficacy data for this sub-group are limited.
  • Sub-Group Findings: In a subset of participants with pre-existing mild hypertension, documentation indicated a variation in the reported incidence of cardiovascular events. The risk profile in these sub-groups requires further characterization.

Frequently Asked Questions (FAQ)

Common questions about Amant (FAQ)


Q: Is Amant considered a first-line treatment for the conditions it addresses?

A: Regulatory guidance indicates that benzodiazepines like Amant are intended for the short-term relief of severe anxiety or distress. They are typically reserved for situations where non-pharmacological methods have been considered or are insufficient. Official product information notes that use is generally limited to a maximum duration of 8 to 12 weeks.


Q: How quickly can a person expect to feel the effects of Amant after starting treatment?

A: According to official product information, the onset of the medicine's therapeutic effects typically occurs within 1 to 2 hours after oral administration. The precise timeframe may vary slightly between individuals.


Q: Why might Amant cause vivid or unusual dreams in some users?

A: Benzodiazepines such as Amant have been associated with psychiatric effects, sometimes referred to as paradoxical reactions. These reactions can include disturbances like agitation and hallucinations. While vivid dreams are not explicitly listed as a common effect in official labeling, they are related to these reported psychiatric changes.


Q: Can Amant cause changes in mood, such as increased anxiety or depression?

A: Official safety data lists psychiatric and paradoxical reactions, including agitation and emotional disturbance. Furthermore, regulatory information notes that Amant is generally not recommended as the primary treatment for patients who have pre-existing depression.


Q: Is it normal to experience difficulty sleeping or insomnia when taking Amant?

A: The medicine is primarily associated with common effects like sedation and drowsiness. However, in some cases, patients may experience paradoxical reactions such as excitability or agitation, which could potentially interfere with normal sleep patterns.


Q: Are there any specific dietary restrictions or concerns while taking Amant?

A: Official product information cautions against the concurrent consumption of grapefruit or grapefruit juice, as these can affect how the medicine is processed by the body. This interaction may potentially increase exposure to the active ingredient.


Q: Is Amant safe for older adults, and what are the specific considerations?

A: Older adults generally require a lower dose and close supervision from a healthcare professional. This is due to increased sensitivity to the effects on the central nervous system (CNS), which can raise the risk of accidental falls.


Q: Does Amant require a patient to have regular blood or heart monitoring?

A: Patients with impaired liver or kidney function are required to have close monitoring and mandatory dose adjustments. However, official regulatory documents do not mandate routine blood or heart monitoring for all patients in general practice.


Q: Can Amant affect a person's blood pressure?

A: Clinical trial data mentions a variation in the incidence of cardiovascular events in certain patient groups, such as those with mild hypertension. However, the drug's effect on blood pressure is not specified as a common or direct adverse effect in the official labeling.


Q: What are the signs of a potential severe or allergic reaction to Amant?

A: Potential severe reactions include symptoms of anaphylactic shock and hypersensitivity. If symptoms of severe sedation or respiratory depression occur, particularly when taken with other central nervous system depressants, immediate medical assistance is necessary.


Q: Can taking Amant affect one's ability to drive or operate machinery?

A: Yes. Due to common side effects such as drowsiness, decreased alertness, and impaired coordination, official product information cautions against driving or operating complex machinery.


Q: What happens if a dose of Amant is missed?

A: General instructions indicate that if a dose is missed, it can be taken when remembered, unless it is nearly time for the next scheduled dose. In that case, the usual guidance is to skip the missed dose and resume the normal schedule. Taking two doses at once is not recommended.


Q: Why do some people report changes in impulse control when taking Amant?

A: Official safety data for Amant lists paradoxical reactions that involve changes in behavior, such as agitation, aggression, and hostility. These behavioral changes are related to alterations in overall control and emotional regulation.


Q: Is it possible to develop a skin rash or other unusual skin changes while on Amant?

A: Post-marketing safety reports for the active ingredient, Bromazepam, include mentions of disorders affecting the skin and underlying tissue. Any new or unusual skin changes should be brought to the attention of a healthcare professional.


Q: What is the history of Amant, and when was it first used?

A: The active ingredient in Amant, Bromazepam, was developed in the mid-1970s. It was subsequently introduced into clinical use in many regions as an established treatment for severe anxiety and tension.


Q: Are there different brand names for the generic drug Amant?

A: Yes, Amant contains the generic active ingredient Bromazepam. This ingredient is marketed under various brand names around the world, including, but not limited to, Lexotan and Lexotanil.


Q: Is there a link between Amant and an increased risk of glaucoma?

A: While Amant's labeling does not explicitly list glaucoma as an adverse effect, the drug class it belongs to (benzodiazepines) is generally noted as having a risk. Caution is advised for its use or avoidance in patients with certain types of glaucoma.


Q: Does Amant impact a person's ability to concentrate or focus?

A: Yes, official product information includes decreased alertness as a common side effect. This reduction in alertness can often impair overall cognitive function, including a person's ability to focus and concentrate.


Q: Can people who have a history of seizures take Amant?

A: Benzodiazepines are widely used in the acute treatment of seizures. However, use of Amant in patients with a history of seizures must be closely managed, as dependence and abrupt withdrawal can sometimes increase the risk of seizures.


Q: How does Amant affect the kidneys or liver?

A: Amant is metabolized primarily by the liver and eliminated by the kidneys. Patients with impaired function of these organs require mandatory dosage adjustments, and severe liver insufficiency is a formal contraindication for use.


Q: How is the correct dosage of Amant generally determined?

A: Dosage is generally determined individually by a healthcare provider. Treatment typically begins with the lowest effective dose, which is then gradually adjusted to find the optimal therapeutic level for the patient.


Q: Do children and teenagers ever take Amant for any conditions?

A: Amant is generally not recommended for patients under 18 years of age because its safety and efficacy have not been formally established in this group. If a physician determines its use is appropriate, the dose must be carefully adjusted based on body weight.


Q: Are there any known interactions between Amant and products containing caffeine?

A: Caffeine is a central nervous system (CNS) stimulant, whereas Amant is a CNS depressant. Although not explicitly detailed in all interaction documents, consuming a stimulant may theoretically counteract the sedative action of a depressant.


Q: Is it true that Amant can sometimes cause changes in a person's body temperature regulation?

A: Studies on the benzodiazepine class have shown that they can potentially affect the body's thermoregulation. This may, in some cases, lead to lower body temperature, particularly in older or frail patients during the initial treatment phase.


Q: Does the effectiveness of Amant wear off over time for some conditions?

A: Benzodiazepines are highly effective when first administered. However, the limit on short-term use is partly due to the risk of developing tolerance, which is when the medicine's effectiveness decreases over time.


Q: What should be done if someone experiences blurred vision while taking Amant?

A: Blurred vision is listed as a potential side effect in the post-marketing data for Amant (Bromazepam). The occurrence of blurred vision should be communicated to a healthcare professional.


Q: Is it typically taken with food or on an empty stomach?

A: According to official administration guidelines, the medicine may be taken either with food or on an empty stomach.


Q: What is the difference between Amant and an antiviral medicine?

A: Amant (Bromazepam) is classified as a benzodiazepine, which acts as an anxiolytic to slow the central nervous system. In contrast, an antiviral medicine is designed to target and inhibit the replication and spread of viruses.


Q: Is Amant associated with any long-term side effects that users should be aware of?

A: Long-term use is strongly discouraged and limited by regulatory bodies. Prolonged use is primarily associated with risks of physical and psychological dependence, a withdrawal syndrome upon cessation, and potential cognitive impairment.

How should Amant be stored and disposed of?

How to Store and Dispose of Amant — Official Regulatory Information

The required storage and disposal of this medicine are defined by official regulatory documentation to maintain its quality and ensure public safety.

Storage & Disposal Scope Official Regulatory Requirements
Labeled Storage Temperature Store at Controlled Room Temperature (20 C to 25 C or 68 F to 77 F). Excursions permitted up to 30 C (86 F).
Protection Requirements Protect from freezing and excessive moisture or light. Keep the container tightly closed and securely sealed.
Child-Protection Storage Keep the medicine out of the sight and reach of children.
Disposal Instructions Do not throw away any unused or expired medicine via wastewater or household waste. Dispose of contents and container according to local, national, and international regulations. Unused medicine may be returned to an approved collection point like a local pharmacy.

Official labeling mandates storage at Controlled Room Temperature and explicitly prohibits freezing, while requiring the use of a tight, light-resistant container. Safe disposal rules direct patients to avoid disposal via household trash or flushing, prioritizing approved take-back programs to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amant found in:

A-Z Index: